Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Return on Equity (2020 - 2025)

Historic Return on Equity for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to 0.54%.

  • Treace Medical Concepts' Return on Equity rose 300.0% to 0.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.54%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.45% for FY2024, which is 600.0% up from last year.
  • Per Treace Medical Concepts' latest filing, its Return on Equity stood at 0.54% for Q3 2025, which was up 300.0% from 0.49% recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Return on Equity peaked at 0.11% during Q3 2021, and registered a low of 97.72% during Q1 2021.
  • Over the past 5 years, Treace Medical Concepts' median Return on Equity value was 0.44% (recorded in 2022), while the average stood at 5.53%.
  • As far as peak fluctuations go, Treace Medical Concepts' Return on Equity plummeted by -46000bps in 2021, and later skyrocketed by 974200bps in 2022.
  • Treace Medical Concepts' Return on Equity (Quarter) stood at 0.22% in 2021, then crashed by -186bps to 0.62% in 2022, then skyrocketed by 41bps to 0.36% in 2023, then tumbled by -42bps to 0.51% in 2024, then fell by -5bps to 0.54% in 2025.
  • Its last three reported values are 0.54% in Q3 2025, 0.49% for Q2 2025, and 0.49% during Q1 2025.